|
|
Volumn 293, Issue 20, 2005, Pages 2462-
|
|
FDA warns antipsychotic drugs may be risky for elderly
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARIPIPRAZOLE;
CLOZAPINE;
FLUOXETINE;
NEUROLEPTIC AGENT;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
ZIPRASIDONE;
BENZODIAZEPINE DERIVATIVE;
DIBENZOTHIAZEPINE DERIVATIVE;
PIPERAZINE DERIVATIVE;
QUINOLONE DERIVATIVE;
THIAZOLE DERIVATIVE;
AGED;
AGING;
BIPOLAR DISORDER;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
DEMENTIA;
DEPRESSION;
DRUG CONTRAINDICATION;
DRUG FATALITY;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
GERIATRIC CARE;
HEART FAILURE;
HUMAN;
INFECTION;
MANIA;
MORTALITY;
PNEUMONIA;
PRIORITY JOURNAL;
REVIEW;
SCHIZOPHRENIA;
SIDE EFFECT;
SUDDEN DEATH;
ARTICLE;
DRUG APPROVAL;
DRUG LABELING;
UNITED STATES;
AGED;
ANTIPSYCHOTIC AGENTS;
BENZODIAZEPINES;
CLOZAPINE;
DEMENTIA;
DIBENZOTHIAZEPINES;
DRUG APPROVAL;
DRUG LABELING;
HUMANS;
PIPERAZINES;
QUINOLONES;
RISPERIDONE;
THIAZOLES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 21044434325
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.293.20.2462 Document Type: Review |
|
Times cited : (98)
|
|
References (0)
|